Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INVION LIMITED Capital/Financing Update 2010

Feb 10, 2010

65148_rns_2010-02-10_866de44d-1e8d-4923-aee8-61f4617d4c6e.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Appendix 1A

ASX Listing application and agreement

This form is for use by an entity seeking admission to the +official list as an ASX Listing (for classification as an ASX Debt Listing use Appendix 1B, and for classification as an ASX Foreign Exempt Listing use Appendix 1C). The form is in 3 parts:

Application for admission to the +official list; 1.

$\mathfrak{p}$ . Information to be completed; and

  1. Agreement to be completed.

Information and documents (including this appendix) given to ASX in support of an application become ASX's property and may be made public. This may be prior to admission of the entity and $\dagger$ quotation of its $\dagger$ securities. Publication does not mean that the entity will be admitted or that its +securities will be quoted.

Introduced 1/7/96. Origin: Appendix 1. Amended 1/7/97, 1/7/98, 1/9/99, 13/3/2000, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005, 20/07/2007.

Part 1 - Application for admission to the official list

Name of entity ACN
CBio Limited 094 730 417

We (the entity) apply for admission to the +official list of ASX Limited (ASX) and for +quotation of +securities.

Part 2 - Information to be completed

About the entity

You must complete the relevant sections (attach sheets if there is not enough space).

All entities

$\mathbf{1}$ Deleted 30/9/2001

$\overline{2}$ +Main class of +securities

Number $+C$ lass
66,476,844 Ordinary Shares
79,826,844
[assuming minimum
subscription
see
section page 2 of
prospectus]
96,826,844
[assuming maximum
subscription
see
section page 2 of
prospectus]
101,826,844
[assuming
over-
subscription
see
section page 2 of
prospectus]
Ordinary shares
3 Additional
+ classes
+ securities (except + CDIs)
of Number
be
to
quoted
79,826,844
[Assuming minimum
subscription]
+ Class
Ordinary Shares
96,826,844
[Assuming
maximum
subscription]
101,826,844
[Assuming
over-
subscription]
22,579,849 Options over Ordinary Shares
Not applicable. Not applicable.
Number not to be
quoted
+ Class
1,330,000 Options over Ordinary Shares
Convertible
6
notes
if
10,000,000
shares
issued
converted
[see section 5.5.2
of prospectus]
6,000,000
options
issued
if
converted
Not applicable Not applicable

$\mathcal{L}^{\text{max}}_{\text{max}}$

$\mathcal{L}^{(1)}$

$\hat{\mathcal{A}}$

$+$ See chapter 19 for defined terms.

4 Telephone
number,
postal
address for all correspondence,
general fax number, fax number
for + company announcements
office to confirm release of
information to the market, and
e-mail address for contact
purposes.
CBio Limited
Brisbane Technology Park
85 Brandl Street
Tel: (07) 3841 4844
Fax: (07) 3341 4200
Email: [email protected]
5 Address of principal + security
registries for each + class of
+ security (including + CDIs)
Link Market Services Ltd
Level 19
324 Queen Street
BRISBANE QLD 4000
6 Annual balance date
Companies only
(Other entities go to 19)
7 title
chief
Name
and
οf
executive
officer/managing
director
Mr Jason Richard Yeates - Managing Director and CEO
8 Name and title of chairperson
of directors
Mr Stephen George Burch Jones - Executive Chairman
9 Names of all directors Mr Stephen George Burch Jones
Mr Jason Richard Yeates
Dr Goran Ando
Professor John Watson Funder
Dr Peter Bartley Corr
Dr Michael Phillip Monsour
Mr Stephen Fredrick Streeter
Dr Dennis John Feeney
10 Duration of appointment of
directors (if not subject to
retirement by rotation) and
details of any entitlement to
participate in profits
The Constitution of CBio Limited is attached as Annexure
2.
Rule 16.1 of the Constitution provides that at every annual
general meeting the number closest to but no less than
one-third of the Directors (except a Managing Director)
shall retire from office. No director (except a Managing
Director) shall retain office for a period in excess of 3
years without submitting for re-election.
Clause 13.3 of the Constitution provides that the Directors'
remuneration is by fixed sum and not a commission on or
percentage of profits (and may not be increased except at a
general meeting where particulars have been given to
shareholders).
11 Name and title of company
secretary
Mr Ben Graham
Company Secretary
12 Place of incorporation Queensland
13 Date of incorporation 11 October 2000
14 Legislation
under
which
incorporated
Corporations Act 2001 (Cth)
15 Address of registered office
in Australia
CBio Limited
'Brisbane Technology Park'
85 Brandl Street
EIGHT MILE PLAINS QLD 4113
16 Month
in
which
annual
meeting is usually held
November
17 Months in which dividends
usually paid
are
(or are
intended to be paid)
There is no current dividend policy and dividends are not
usually paid as the company is not generating profits. This
is explained in section 5.6.1 of the Prospectus.
18 If the entity is a foreign
which
has
company
a
certificated
subregister
for
+ securities,
quoted
the
of
location
Australian
*security registers
Not applicable.

$\hat{\boldsymbol{z}}$

+ See chapter 19 for defined terms.

18A - If the entity is a foreign $\vert$ Not
company, the name and
address of the entity's
Australian agent for service
of process

applicable.

$\bar{\gamma}$

(Companies now go to 31)

$\bar{\gamma}$

All entities except companies

19 and title of chief
Name
executive
officer/managing
director of the responsible
entity
Not applicable.
20 Name and title of chairperson
of directors of responsible
entity
Not applicable.
21 Names of all directors of the
responsible entity
Not applicable.
22 Duration of appointment of
directors of responsible entity
(if not subject to retirement by
rotation) and details of any
entitlement to participate in
profits
Not applicable.
23 Name and title of company
secretary of responsible entity
Not applicable.
23A Trusts only - the names of the
members of the compliance
committee (if any)
Not applicable.
24 Place of registration of the
entity
Not applicable.
25 Date of registration of the
entity
Not applicable.
26 Legislation under which the
entity is registered
Not applicable.
27 of
administration
Address
office in Australia of the entity
Not applicable.
28 If an annual meeting is held,
month in which it is usually
held
Not applicable.
29 Months in which distributions
usually paid
(or
are
are
intended to be paid)
Not applicable.
30 If the entity is a foreign entity
which
has
certificated
a i
subregister
for
quoted
*securities, the location of
Australian + security registers
Not applicable.
30A If the entity is a foreign trust,
the name and address of the
Not applicable.
entity's Australian agent for
service of process

$\mathcal{L}^{\pm}$

$\ddot{\phantom{a}}$

$+$ See chapter 19 for defined terms.

About the entity

All entities

documents Tick to indicate you are providing the information or Where is the information or document
to be found?
(eg, prospectus cross
reference)
31 Evidence of compliance with 20 cent minimum
issue price or sale price, and spread requirements
\$1.00 issue price. The Prospectus
is attached as Annexure 1.
See:
Prospectus section 1.1.
32 Prospectus, Product Disclosure Statement or
information
memorandum
relevant
to
the
application (250 copies)
of the Prospectus
A
copy
is.
Please let us know if
attached.
further copies are required.
33 Cheque for fees the
cheque
in
of
A
amount
\$164,890.52 (inclusive of GST) is
attached. [this is calculated on
101,826,844 shares at \$1.00 per
share and 22,579,849 options with
an exercise price of \$1.00]
34 Type of subregisters the entity will operate
Example: CHESS and certificated subregisters
CHESS
35 Copies of any contracts referred to in the
prospectus, Product Disclosure Statement or
information memorandum
(including)
any
underwriting agreement)
Copies of the material contracts
referred to in sections 8.3 to 8.11 of
the Prospectus are provided as
Annexures 3 to 14.
36 A certified copy of any restriction agreement
entered into in relation to + restricted securities
Certified copies of the applicable
restriction agreements are to be
provided.
37 If there are + restricted securities, undertaking
issued by any bank or + recognised trustee
Not applicable.
38 (Companies only) - certificate of incorporation
or other evidence of status (including any change
of name)
Certificate of registration on change
of name (conversion to public
company) is attached as Annexure
15.

$+$ See chapter 19 for defined terms.

-39 (All entities except companies) - certificate of Not applicable.
registration or other evidence of status (including
change of name)
40 Copy of the entity's constitution (eg, if a The Constitution of CBio Limited company, the memorandum and articles of is attached as Annexure 2. Note
association)
clause 28.2 which provides ASX
Listing Rules prevail (per Appendix
15A).

+ See chapter 19 for defined terms.

Where is the information or document
to be found?
(eg, prospectus cross
reference)
41 Completed checklist that the constitution
complies with the listing rules (copy of articles
checklist is available from any Companies
Department)
To be provided. Note clause 28.2
of the Constitution which provides
ASX Listing Rules prevail (per
Appendix 15A).
42 A brief history of the entity or, if applicable, the
group
See Prospectus section 2.1.
42 A Copy of agreement with ASX that documents
may be given to ASX and authenticated
electronically.
A copy of this agreement
is.
attached as Annexure 20.
About the securities to be quoted
All entities
43 Confirmation that the + securities to be quoted
are eligible to be quoted under the listing rules
See Prospectus section 1.11.
44 Voting rights of + securities to be quoted See rule 12.1 of the Company's
Constitution.
45 A specimen certificate/holding statement for
each + class of + securities to be quoted and a
To
be provided.
Link
Market
Services are the share registry.
46 specimen holding statement for + CDIs
Terms of the + securities to be quoted
Please see rule 3 of the company
constitution, and section 1.2 of the
Prospectus.
47 A statement setting out the names of the 20
largest holders in each + class of + securities to be
quoted, and the number and percentage of each
+ class of + securities held by those holders
To be provided after the allotment
of shares and completion of Offer
under the Prospectus.
48 A distribution schedule of each + class of + equity
securities to be quoted, setting out the number
of holders in the categories -
$1 - 1,000$
$1,001 - 5,000$
$5,001 - 10,000$
10,001 - 100,000
100,001 and over
To be provided after the allotment
of shares and completion of Offer
under the Prospectus.
49 The number of holders of a parcel of + securities
with a value of more than \$2,000, based on the
issue/sale price
To be provided after the allotment
of shares and completion of Offer
under the Prospectus.

$\hat{\mathcal{A}}$

$\bar{1}$

$+$ See chapter 19 for defined terms.

50 Terms of any + debt securities and + convertible
debt securities
convertible
6
issued
notes
subsequent to 30 June 2009 under a
Convertible Note Deed dated 30
August 2007 and are currently on
issue and total \$5,000,000. See
section 5.5.2, 5.5.4 and 5.7.22
Where is the information or document
to be found? (eg, prospectus cross
reference)
51 Trust deed for any + debt securities
and
+ convertible debt securities
The Convertible Note Deed dated
30 August 2007 is attached as
Annexure 16.
52 Deleted 24/10/2005.

All entities with classified assets

(Other entities go to 62)

All +mining exploration entities and, if ASX asks, any other entity that has acquired, or entered into an agreement to acquire a $\text{*}\text{classified asset},$ must give ASX the following information.

53 The name of the vendor and details of any
relationship of the vendor with us
Not applicable.
54 If the vendor was not the beneficial owner of the
+ classified asset at the date of the acquisition or
agreement, the name of the beneficial owner(s)
and details of the relationship of the beneficial
$owner(s)$ to us
Not applicable.
55 The date that the vendor acquired the + classified
asset
Not applicable.
56 The method by which the vendor + acquired the
+ classified
asset,
including
whether
by
agreement, exercise of option or otherwise
Not applicable.
57 The consideration passing directly or indirectly
from the vendor (when the vendor "acquired the
asset), and whether the consideration has been
provided in full
Not applicable.
58 Full details of the + classified asset, including any
title particulars
Not applicable.

$+$ See chapter 19 for defined terms.

$\hat{u}$

$\mathcal{A}^{\text{max}}_{\text{max}}$

$\hat{\mathcal{A}}$

$+$ See chapter 19 for defined terms.

document to be found? (eg, prospectus cross reference) 59 The work done by or on behalf of the vendor in Not applicable. developing the +classified asset. In the case of a +mining tenement, this includes prospecting in relation to the tenement. If money has been spent by the vendor, state the amount (verification of which may be required by ASX). 60 The date that the entity +acquired the +classified Not applicable. asset from the vendor, the consideration passing directly or indirectly to the vendor, and whether that consideration has been provided in full 61 A breakdown of the consideration, showing how Not applicable. it was calculated, and whether any experts' reports were commissioned or considered (and if so, with copies attached).

Where is the information or

About the entity's capital structure

All entities

62 Deleted 1/9/99.
63 A copy of the register of members, if ASX asks To be provided if requested by
ASX.
64 A copy of any court orders in relation to a
reorganisation of the entity's capital in the last
five years
Not applicable.
65 The terms of any + employee incentive scheme Employee Share Option Plan is
attached
Annexure
as
7.
$\mathbf{A}$
summary of the Plan is contained in
section 8.8 of the Prospectus.
66 The terms of any + dividend or distribution plan Not applicable.
67 The terms of any + securities that will not be Not applicable.
quoted
68 Deleted 1/7/98.

$+$ See chapter 19 for defined terms.

to be found?
(eg, prospectus cross
reference)
69 The entity's issued capital (interests), showing
separately each + class of + security (except
+ CDIs), the amount paid up on each + class, the
issue price, the dividend (in the case of a trust,
distribution) and voting rights attaching to each
+ class and the conversion terms (if applicable)
The Company has 66,476,844 fully
paid ordinary shares on issue and
23,909,849 options.
No dividends have been paid to
date.
The rights attaching to these shares
are set out in the Company's
Constitution which is attached as
Annexure 2. See also section 8.2 of
the Prospectus.
convertible
6
remain
notes
currently
totalling
issue
on
\$5million. See section 5.5.2 of the
Prospectus.
A copy of the
convertible note deed is attached as
Annexure 16.
70 The number of the entity's debentures, except to
showing the amount outstanding,
bankers,
nominal value and issue price, rate of interest,
dates of payment of interest, date and terms of
redemption of each + class and conversion terms
(if applicable)
Note: This applies whether the securities are quoted or not.
Not applicable.
71 The number of the entity's unsecured notes,
showing the amount outstanding, nominal value
and issue price, rate of interest, dates of payment
of interest, date and terms of redemption of each
*class and conversion terms (if applicable)
Note: This applies whether the securities are quoted or not.
Not applicable.
72 The number of the entity's options to $^+$ acquire
unissued
+ securities,
showing
the
number
outstanding
Note: This applies whether the securities are quoted or not.
As at the date of the prospectus the
Company had 23,909,849
share
options issued.
73 Details of any rights granted to any + person, or to
any class of + persons, to participate in an issue of
the entity's + securities
Note: This applies whether the securities are quoted or not.
See item 65.
74 If the entity has any + child entities, a list of all
+ child entities stating in each case the name, the
nature of its business and the entity's percentage
holding in it. Similar details should be provided
for every entity in which the entity holds (directly
or indirectly) 20% or more of the issued capital
(interests).
Not applicable.

$\hat{\boldsymbol{\beta}}$

$\hat{\mathcal{A}}$

$\ddot{\phantom{a}}$

Where is the information or document

$\hat{\boldsymbol{\beta}}$

$\bar{\beta}$

$+$ See chapter 19 for defined terms.

$\mathcal{A}^{\mathcal{A}}$

$\hat{\mathcal{A}}$

$\sim 10$

$\hat{A}$ , $\hat{A}$

$+$ See chapter 19 for defined terms.

About the entity's financial position
(Entities meeting the profit test go to 75. For the assets test go to 81A.)

All entities meeting the profit test

Where is the information or document
to be found?
(eg, prospectus cross
reference)
75 Evidence that the entity has been in the same
main business activity for the last 3 full
financial years
Not applicable.
76 Evidence that the entity is a going concern (or
successor) and its aggregated profit for the last
3 full financial years
Not applicable.
76A Evidence
that the
entity's + profit from
continuing operations in the past 12 months
exceeded \$400,000
Not applicable.
77 Audited + accounts for the last 3 full financial
years and audit reports
Not applicable.
$78 - 79$ Deleted 1/7/97.
80 Half yearly + accounts (if required) and audit
report or review
Not applicable.
80A Pro forma balance sheet and review Not applicable.
80B Statement from all directors or all directors of
the responsible entity confirming that the entity
is continuing to earn + profit from continuing
operations
Not applicable.
All entities meeting the assets test
(only complete one of 81A, 81B or 81C and one of 82 or 83)
81 Introduced 1/7/96. Amended 1/7/99.
Deleted 1/7/97
81A For entities other than + investment entities,
evidence of net tangible assets of at least \$2
million or market capitalisation of at least \$10
million
See sections
5
and
- 6
of the
Prospectus. The report of Ernst $\&$
Young is attached as Annexure 17.
Accounts are attached as Annexure
18.
81B For + investment entities other than + pooled
development funds, evidence of net tangible
assets of at least \$15 million
Not applicable.
81C Evidence that the entity is
+pooled
a
development fund with net tangible assets of at
least \$2 million
Not applicable.

$+$ See chapter 19 for defined terms.

Where is the information or document to (eg, prospectus cross) be found? reference)

$\bar{\mathcal{A}}$

82 Evidence that at least half of the entity's total
tangible assets (after raising any funds) is not
cash or in a form readily convertible to cash (if
there are no-commitments)
Not applicable.
83 Evidence that there are commitments to spend at
least half of the entity's cash and assets in a
form readily convertible to cash (if half or more
of the entity's total tangible assets (after raising
any funds) is cash or in a form readily
convertible to cash)
See sections 1.4 and 6 of the
Prospectus and the report of Ernst
& Young which is attached as
Annexure
17.
Accounts
are
attached as Annexure 18.
84 Statement that there is enough working capital
to carry out the entity's stated objectives (and
statement by independent expert, if required)
See sections 1.4 and 6 of the
Prospectus, and the report of Ernst
& Young which is attached as
Annexure 17. Accounts attached as
Annexure 18.
85 Deleted 1/9/99.
86 Deleted 1/7/97.
87 *Accounts for the last 3 full financial years and
audit report, review or statement that not
audited or not reviewed
See sections 5 and 6 of the
Prospectus. The report of Ernst $\&$
Young is attached as Annexure 17.
Accounts are attached as Annexure
18.
87A Half yearly + accounts (if required) and audit
report, review or statement that not audited or
not reviewed
Not applicable.
87B Audited balance sheet (if required) and audit
report
See sections 5 and
6 of the
Prospectus. The report of Ernst &
Young is attached as Annexure 17.
Accounts are attached as Annexure
18.
87C Pro forma balance sheet and review See sections
$5^{\circ}$
and
6
of the
Prospectus. The report of Ernst $\&$
Young is attached as Annexure 17.
Accounts are attached as Annexure
18.
(Now go to 106)
88 Deleted 1/7/97.

89-92C Deleted 1/9/99.

$\sim$

$\mathcal{A}^{\mathcal{A}}$

$+$ See chapter 19 for defined terms.

93 Deleted 1/7/97.
94-98C Deleted 1/9/99.
99 Deleted 1/7/97.
100-105C Deleted 1/9/99.

$\mathcal{L}^{\text{max}}_{\text{max}}$

$\sim$

$\label{eq:2.1} \frac{1}{\sqrt{2}}\sum_{i=1}^n\frac{1}{\sqrt{2}}\sum_{i=1}^n\frac{1}{\sqrt{2}}\sum_{i=1}^n\frac{1}{\sqrt{2}}\sum_{i=1}^n\frac{1}{\sqrt{2}}\sum_{i=1}^n\frac{1}{\sqrt{2}}\sum_{i=1}^n\frac{1}{\sqrt{2}}\sum_{i=1}^n\frac{1}{\sqrt{2}}\sum_{i=1}^n\frac{1}{\sqrt{2}}\sum_{i=1}^n\frac{1}{\sqrt{2}}\sum_{i=1}^n\frac{1}{\sqrt{2}}\sum_{i=1}^n\frac$

$\sim$ $\sim$

$+$ See chapter 19 for defined terms.

About the entity's business plan and level of operations

All entities

Information
memorandum
contained the
in
information Where is the information or document
to be found?
(eg, prospectus cross
reference)
106 Details of the entity's existing and proposed activities,
and level of operations. State the main business
The main business of CBio Limited
is the research and development of
technologies for the treatment of
autoimmune diseases.
See section 2 of the Prospectus for
details of CBio's existing and
proposed activities and level of
operations.
107 Details of any issues of the entity's + securities (in all See table attached as Annexure 21.

+classes) in the last 5 years. Indicate issues for
consideration other than cash

$\bar{a}$

Information memorandum requirements

All entities

108 If the entity is a company, a statement that all
the information that would be required under
section 710 of the Corporations Act if the
information memorandum were a prospectus
offering for subscription the same number of
securities for which quotation will be sought
is contained in the information memorandum.
If the entity is a trust, a statement that all the
information that would be required under
section 1013C of the Corporations Act if the
information memorandum were a Product
Disclosure Statement offering for subscription
the same number of + securities for which
+ quotation will be sought is contained in the
information memorandum
Not applicable.
109 The signature of every director, and proposed
director, of the entity personally or by a + person
authorised in writing by the director (in the case
of a trust, director of the responsible entity)
Not applicable.
110 The date the information memorandum is signed Not applicable.
111(a) Full particulars of the nature and extent of any
interest now, or in the past 2 years, of every
director or proposed director of the entity (in the
case of a trust, the responsible entity), in the
promotion of the entity, or in the property
acquired or proposed to be acquired by it
Not applicable.

<sup>+ See chapter 19 for defined terms.

$111(b)$

$\hat{\mathcal{A}}$

$\bar{\mathcal{A}}$

If the interest was, or is, as a member or partner
in another entity, the nature and extent of the
interest of that other entity

Not applicable.

$+$ See chapter 19 for defined terms.

Information contained in the information memorandum Where is the information or document
to be found?
(eg, prospectus cross
reference)
111(c) If the interest was or is as a member or partner
in another entity, a statement of all amounts
paid or agreed to be paid to him or her or the
entity in cash, + securities or otherwise by any
+ person to induce him or her to become or to
qualify him or her as, a director, or for services
rendered by him or her or by the entity in
connection with the promotion or formation of
the listed entity
Not applicable.
112(a) Full particulars of the nature and extent of any
interest of every expert in the promotion of the
entity, or in the property acquired or proposed
to be acquired by it
Not applicable.
112(b) If the interest was or is as a member or partner
in another entity, the nature and extent of the
interest of that other entity
Not applicable.
112(c) If the interest was or is as a member or partner in
another entity, a statement of all amounts paid or
agreed to be paid to him or her or the entity in
cash, + securities or otherwise by any + person for
services rendered by him or her or by the entity in
connection with the promotion or formation of
the listed entity
Not applicable.
113 A statement that ASX does not take any
responsibility for the contents of the information
memorandum
Not applicable.
114 A statement that the fact that ASX may admit the
entity to its + official list is not to be taken in any
way as an indication of the merits of the entity
Not applicable.
115 If the information memorandum includes a
statement claiming to be made by an expert or
based on a statement made by an expert, a
statement that the expert has given, and has not
withdrawn, consent to the issue of the information
memorandum with the particular statement
included in its form and context
Not applicable.

$\bar{\mathcal{A}}$

$+$ See chapter 19 for defined terms.

Where is the information or document to be found? (eg, prospectus cross reference)

116 A statement that the entity has not raised any capital
for the 3 months before the date of issue of the
information memorandum and will not need to raise
any capital for 3 months after the date of issue of the
information memorandum
Not applicable.
117 A statement that a supplementary information
memorandum will be issued if the entity becomes
+ aware of any of the following between the issue of
the information memorandum and the date the
entity's + securities are + quoted or reinstated.
A material statement in the information
۰
memorandum is misleading or deceptive.
There is a material omission from the information
٠
memorandum.
There has been a significant change affecting a
matter included in the information memorandum.
A significant new circumstance has arisen and it
would have been required to be included in the
information memorandum
Not applicable.

Information contained in the supplementary information memorandum

118 If
there is
a supplementary
memorandum:
information Not applicable.
Correction of any deficiency.
Details of any material omission, change or new
matter.
• A prominent statement that it is a supplementary
information memorandum.
The signature of every director, or proposed
director, of the entity personally or by a + person
authorised in writing by the director (in the case
of a trust, director of the responsible entity).
supplementary
date the
information
The
memorandum is signed.

Evidence if supplementary information memorandum is issued

119

Evidence that the supplementary information Not applicable.
memorandum accompanied every copy of the
information memorandum issued after the date of the 1
supplementary information memorandum.

$+$ See chapter 19 for defined terms.

$\bar{z}$

Other information

All entities

Where is the information or document
to be found? (eg, prospectus cross
reference)
120 Evidence that the supplementary information
memorandum was sent to every + person who
was sent an information memorandum
Not applicable.
121 Details of any material contracts entered into
between the entity and any of its directors (if a
trust, the directors of the responsible entity)
Transactions with related parties are
set out in section 9.8.2 of the
Prospectus.
122 A copy of every disclosure document or Product
Disclosure
Statement
issued,
and
every
information memorandum circulated, in the last
5 years
Attached as Annexure 19.
123 Information not covered elsewhere and which,
in terms of rule 3.1, is likely materially to affect
the price or value of the entity's + securities
Not applicable.
123A The documents which would have been required
to be given to ASX under rules $4.1, 4.2, 4.3, 4.5,$
5.1, 5.2 and 5.3 had the entity been admitted to
the $\pm$ official list at the date of its application for
admission, unless ASX agrees otherwise.
Example: ASX may agree otherwise if the entity was recently
incorporated.
To be provided if requested by
ASX, where applicable.
Mining exploration entities

124 A map or maps of the mining tenements prepared Not applicable. by a qualified +person. The maps must indicate the geology and other pertinent features of the tenements, including their extent and location in relation to a capital city or major town, and relative to any nearby properties which have a significant bearing on the potential of the tenements. The maps must be dated and identify the qualified *person and the report to which they relate.

125 Deleted 1/7/97

<sup>+ See chapter 19 for defined terms.

Where is the information or document to
be found? (eg, prospectus cross reference)

126 A schedule of + mining tenements prepared by a
The schedule must state in
qualified person.
relation to each + mining tenement:
the geographical area where the
$+$ mining
tenement is situated;
the nature of the title to the + mining tenement;
whether the title has been formally confirmed or
approved and, if not, whether an application for
confirmation or approval is pending and whether
the application is subject to challenge; and
the + person in whose name the title to the
+ mining tenement is currently held.
Not applicable.
127 If the entity has + acquired an interest or entered
into an agreement to + acquire an interest in a
+ mining tenement from any + person, a statement
detailing the date of the + acquisition of the
interest from the vendor and the purchase price
paid and all other consideration (whether legally
enforceable or not) passing (directly
or
indirectly) to the vendor.
Not applicable.
128 A financial statement by the directors (if a trust,
the directors of the responsible entity) setting out
a program of expenditure together with a
timetable for completion of an exploration
program in respect of each + mining tenement or,
where appropriate, each group of tenements
Not applicable.
129 A declaration of conformity or otherwise with the
Australasian Code for Reporting of Identified
Mineral Resources and Ore Reserves for any
reports on mineral resources and + ore reserves
Not applicable.

$+$ See chapter 19 for defined terms.

Part 3 - Agreement

All entities

You must complete this agreement. If you require a seal to be bound, the agreement must be under seal.

We agree:

  • Our admission to the +official list is in ASX's absolute discretion. ASX may admit us $\mathbf{1}$ on any conditions it decides. +Quotation of our +securities is in ASX's absolute discretion. ASX may quote our 'securities on any conditions it decides. Our removal from the +official list or the suspension or ending of +quotation of our +securities is in ASX's absolute discretion. ASX is entitled immediately to suspend +quotation of our *securities or remove us from the *official list if we break this agreement, but the absolute discretion of ASX is not limited.
  • $\overline{2}$ We warrant the following to ASX.
  • The issue of the 'securities to be quoted complies with the law, and is not for an illegal purpose.
  • There is no reason why the +securities should not be granted +quotation.
  • An offer of the *securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any *securities to be quoted and that no-one has any right to return any *securities to be quoted under sections 601MB(1), 737, 738, 992A, 992AA or 1016F of the Corporations Act at the time that we request that the *securities be quoted.
  • If we are a trust, we warrant that no person has the right to return the *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the 'securities be quoted.
  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from, or connected with, any breach of the warranties in this agreement.
  • We give ASX the information and documents required by this form. If any information 4 or document is not available now, we will give it to ASX before 'quotation of the *securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

<sup>+ See chapter 19 for defined terms.

  • 5 We will comply with the listing rules that are in force from time to time, even if +quotation of our +securities is deferred, suspended or subject to a +trading halt.
  • 6 The listing rules are to be interpreted:
  • in accordance with their spirit, intention and purpose;
  • by looking beyond form to substance; and
  • in a way that best promotes the principles on which the listing rules are based.
  • $\overline{7}$ ASX has discretion to take no action in response to a breach of a listing rule. ASX may also waive a listing rule (except one that specifies that ASX will not waive it) either on our application or of its own accord on any conditions. ASX may at any time vary or revoke a decision on our application or of its own accord.
  • 8 A document given to ASX by an entity, or on its behalf, becomes and remains the property of ASX to deal with as it wishes, including copying, storing in a retrieval system, transmitting to the public, and publishing any part of the document and permitting others to do so. The documents include a document given to ASX in support of the listing application or in compliance with the listing rules.
  • 9 In any proceedings, a copy or extract of any document or information given to ASX is of equal validity in evidence as the original.
  • 10 Except in the case of an entity established in a jurisdiction whose laws have the effect that the entity's +securities cannot be approved under the operating rules of the +approved CS facility:
  • We will satisfy the +technical and performance requirements of the *approved CS facility and meet any other requirements the *approved CS facility imposes in connection with approval of our +securities.
  • When +securities are issued we will enter them in the +approved CS facility's subregister holding of the applicant before they are quoted, if the applicant instructs us on the application form to do so.
  • The +approved CS facility is irrevocably authorised to establish and administer a subregister in respect of the *securities for which *quotation is sought.

<sup>+ See chapter 19 for defined terms.

Except in the case of an entity established in a jurisdiction whose laws have the 11 effect that the entity's 'securities cannot be approved under the operating rules of the +approved CS facility, we confirm that either:

we have given a copy of this application to the 'approved CS facility in accordance with the operating rules of the +approved CS facility ; or

we ask ASX to forward a copy of this application to the +approved CS facility.

  • 12 In the case of an entity established in a jurisdiction whose laws have the effect that the entity's +securities cannot be approved under the operating rules of the +approved CS facility:
  • The +approved CS facility is irrevocably authorised to establish and administer a subregister in respect of +CDIs.
  • We will make sure that +CDIs are issued over +securities if the holder of quoted *securities asks for *CDIs.
  • In the case of an entity established in a jurisdiction whose laws have the effect that the 13 entity's +securities cannot be approved under the operating rules of the +approved CS facility:

we have given a copy of this application to the approved CS facility in accordance with the operating rules of the 'approved CS facility; or

we ask ASX to forward a copy of this application to the +approved CS facility.

EXECUTED for and on behalf of CBIO LIMITED ACN 094 730 417 in accordance with its constitution in the presence of:

%atrs

A Director

Jason Richard Yeates

Full name of Director $\blacktriangle$

'ny fifi

Company Secretary

Benjamin Lee Graham

Full Name of Company Secretary A

Appendix 1A Page 26

5440307v1

3/5/2004

$+$ See chapter 19 for defined terms.